STOCK TITAN

PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)

PetIQ announced the successful completion of its $1.5 billion acquisition by Bansk Group, a consumer-focused private investment firm. Under the terms, PetIQ stockholders will receive $31.00 in cash per share. Following the transaction, PetIQ has been delisted from Nasdaq and is now privately held, continuing operations independently under its current executive team. The partnership aims to accelerate PetIQ's mission of providing affordable pet healthcare while pursuing growth initiatives through strategic investments in marketing, innovation, and potential acquisitions.

PetIQ ha annunciato il completamento con successo della sua acquisizione da 1,5 miliardi di dollari da parte di Bansk Group, una società di investimento privato focalizzata sui consumatori. Secondo i termini dell'accordo, gli azionisti di PetIQ riceveranno 31,00 dollari in contante per azione. Dopo la transazione, PetIQ è stata rimossa dal Nasdaq e ora è di proprietà privata, continuando le sue operazioni in modo indipendente sotto l'attuale team esecutivo. La partnership mira ad accelerare la missione di PetIQ di fornire assistenza sanitaria per animali domestici accessibile, perseguendo iniziative di crescita attraverso investimenti strategici nel marketing, nell'innovazione e in potenziali acquisizioni.

PetIQ anunció la finalización exitosa de su adquisición de 1.5 mil millones de dólares por Bansk Group, una firma de inversión privada enfocada en el consumidor. Según los términos, los accionistas de PetIQ recibirán 31.00 dólares en efectivo por acción. Tras la transacción, PetIQ ha sido excluida de Nasdaq y ahora es una empresa privada, continuando sus operaciones de manera independiente bajo su actual equipo ejecutivo. La asociación tiene como objetivo acelerar la misión de PetIQ de proporcionar atención médica asequible para mascotas mientras persigue iniciativas de crecimiento a través de inversiones estratégicas en marketing, innovación y posibles adquisiciones.

PetIQ는 Bansk Group이라는 소비자 중심의 사모 투자 회사에 의해 15억 달러의 인수가 성공적으로 완료되었다고 발표했습니다. 계약 조건에 따르면 PetIQ 주주들은 주당 31달러의 현금을 받을 것입니다. 거래 후, PetIQ는 나스닥에서 상장 폐지되었고 이제 개인 소유로 운영되며 현재의 경영진 아래에서 독립적으로 운영을 지속합니다. 이 파트너십은 PetIQ의 저렴한 반려동물 의료 제공 임무를 가속화하고 마케팅, 혁신 및 잠재적 인수에 대한 전략적 투자를 통해 성장 이니셔티브를 추구하는 것을 목표로 하고 있습니다.

PetIQ a annoncé l'achèvement réussi de son acquisition de 1,5 milliard de dollars par Bansk Group, une société d'investissement privé axée sur le consommateur. Selon les conditions, les actionnaires de PetIQ recevront 31,00 dollars en espèces par action. Suite à la transaction, PetIQ a été retirée de Nasdaq et est désormais détenue en privé, poursuivant ses opérations de manière indépendante sous son équipe dirigeante actuelle. Le partenariat vise à accélérer la mission de PetIQ de fournir des soins de santé abordables pour les animaux de compagnie tout en poursuivant des initiatives de croissance grâce à des investissements stratégiques dans le marketing, l'innovation et les acquisitions potentielles.

PetIQ gab bekannt, dass die 1,5 Milliarden Dollar Übernahme durch die Bansk Group, eine auf Verbraucher fokussierte private Beteiligungsgesellschaft, erfolgreich abgeschlossen wurde. Nach den Vertragsbedingungen erhalten die Aktionäre von PetIQ 31,00 Dollar in bar pro Aktie. Nach der Transaktion wurde PetIQ von Nasdaq delistet und ist jetzt in Privatbesitz, während es seine Geschäfte unabhängig unter dem aktuellen Führungsteam fortsetzt. Die Partnerschaft zielt darauf ab, die Mission von PetIQ, erschwingliche Gesundheitsversorgung für Haustiere anzubieten, zu beschleunigen und Wachstumsinitiativen durch strategische Investitionen in Marketing, Innovation und potenzielle Übernahmen voranzutreiben.

Positive
  • All-cash transaction valued at $1.5 billion
  • Shareholders receive $31.00 per share in cash
  • Company maintains operational independence under current management
  • Strategic partnership enables acceleration of growth initiatives
Negative
  • Delisting from Nasdaq reduces public trading liquidity for investors
  • Current shareholders lose potential future upside as company goes private

Insights

The $1.5 billion all-cash acquisition of PetIQ by Bansk Group marks a significant premium for shareholders, who will receive $31.00 per share. The deal represents a strategic shift from public to private ownership, allowing for more flexible long-term growth initiatives without quarterly earnings pressure. Bansk Group's expertise in consumer brands and operational improvements could accelerate PetIQ's market penetration in the growing pet healthcare sector.

The transaction comes at an opportune time in the pet care industry, which has shown resilience despite economic headwinds. With Bansk's capital and strategic support, PetIQ can pursue aggressive expansion through both organic growth and strategic acquisitions. The company's transition to private ownership should enable faster decision-making and more substantial investments in marketing and innovation.

This acquisition aligns with broader consolidation trends in the pet care industry, where private equity firms are actively seeking established platforms with strong growth potential. The pet health and wellness sector continues to demonstrate recession-resistant characteristics, with pet parents maintaining spending on essential healthcare products and services. Bansk's focus on consumer brands positions them well to enhance PetIQ's market presence and potentially capture a larger share of the expanding pet healthcare market through improved marketing strategies and product innovation.

EAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the successful completion of its acquisition by Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, in an all-cash transaction valued at approximately $1.5 billion.

PetIQ stockholders will receive $31.00 in cash per PetIQ share in accordance with the terms of the transaction. With the completion of the transaction, PetIQ shares no longer trade on and will be delisted from the Nasdaq stock exchange. PetIQ is now a privately held company and continues to be operated independently by the Company’s executive team.

“We’re pleased to have delivered significant value for PetIQ stockholders through the completion of our transaction with Bansk Group,” commented Cord Christensen, Founder, Chairman and CEO of PetIQ. “Through our partnership with Bansk, we look forward to accelerating our mission of providing pet parents convenient access to affordable pet healthcare while accelerating many longer-term growth initiatives for PetIQ’s continued success.”

“We’re thrilled to partner with Cord and the entire PetIQ team. Together, we look forward to building on the Company’s strong momentum as a leading pet health and wellness platform,” said Chris Kelly, Senior Partner of Bansk Group. “By leveraging our extensive brand, marketing and operational experience, we see clear runway to expand and enhance PetIQ’s capabilities and offerings for pet parents.”

“We believe PetIQ is poised for continued success in the resilient and very attractive pet health and wellness category,” said Bart Becht, Senior Partner and Chairman of Bansk Group. “We look forward to supporting the talented PetIQ team in its next phase of growth, through strategic investments in marketing and innovation as well as strategic acquisitions.”

Advisors

Jefferies LLC served as financial advisor and Cooley LLP served as legal counsel to PetIQ. Davis Polk & Wardwell LLP served as legal counsel to Bansk Group.

About PetIQ

PetIQ is a leading pet medication, health and wellness company delivering a smarter way for pet parents to help their pets live their best lives through convenient access to affordable products and veterinary services. The Company's product business engages with pet parents through retail and e-commerce sales channels with its branded and distributed pet medications as well as health and wellness items. PetIQ manufactures and distributes pet products from its world-class facilities in Omaha, Nebraska, Springville, Utah and Daytona Beach, Florida. The Company’s veterinarian services offering operates in over 2,600 mobile community clinic locations and wellness centers hosted at retail partners in 39 states. PetIQ believes that pets are an important part of the family and deserve the best products and care we can provide them.

About Bansk Group

Founded in 2019, Bansk Group is a New York-based private investment firm focused on investing in and building distinctive consumer brands. The firm partners with differentiated brands across four primary consumer categories: beauty & personal care, consumer health, food & beverage, and household products.

Over their careers with Bansk and elsewhere, Bansk's tenured group of investors and operators have been involved in more than $30 billion of equity capital investments across more than 40 transactions with some of the most innovative and well-known consumer companies in the world. With extensive investment experience in the consumer products industry, a global network of relationships, and a tested value creation playbook, Bansk seeks to partner with exceptional founders and management teams to drive outsized organic and acquisitive growth and position brands for enduring long-term success in the evolving consumer landscape. www.banskgroup.com

Contacts

For PetIQ, Inc.:
Investors: katie.turner@petiq.com or 208.513.1513
Media: kara.schafer@petiq.com or 407.929.6727

For Bansk Group:
Media:
Woomi Yun / Erik Carlson / Madeline Jones
Joele Frank, Wilkinson Brimmer Katcher
+1 (212) 355-4449

Notice Regarding Forward-Looking Statements

This communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the benefits of the transaction with Bansk Group. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Company management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and may differ from assumptions. Many actual events and circumstances are beyond the control of the Company.

Further information on factors that could cause actual results to differ materially from the results anticipated by the forward-looking statements is included in the definitive proxy statement filed by the Company with the Securities and Exchange Commission on September 16, 2024, in connection with the Agreement, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings made by the Company from time to time with the Securities and Exchange Commission. These filings, when available, are available on the investor relations section of the Company’s website at https://ir.petiq.com/ or on the SEC’s website at https://www.sec.gov. If any of these risks materialize or any of these assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that the Company presently does not know of or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. The forward-looking statements included in this communication are made only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law.


FAQ

What is the value of Bansk Group's acquisition of PetIQ (PETQ)?

The acquisition of PetIQ by Bansk Group is an all-cash transaction valued at approximately $1.5 billion.

How much will PetIQ (PETQ) shareholders receive per share in the Bansk acquisition?

PetIQ shareholders will receive $31.00 in cash per share as part of the acquisition deal.

Will PetIQ (PETQ) continue trading on Nasdaq after the Bansk acquisition?

No, PetIQ shares will no longer trade on and will be delisted from the Nasdaq stock exchange as the company becomes privately held.

Who will manage PetIQ after the Bansk Group acquisition?

PetIQ will continue to be operated independently by the Company's existing executive team after the acquisition.

PetIQ, Inc.

NASDAQ:PETQ

PETQ Rankings

PETQ Latest News

PETQ Stock Data

918.69M
29.67M
7%
102%
3.42%
Drug Manufacturers - Specialty & Generic
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States of America
EAGLE